University of Sydney researchers have identified a proposed circadian subtype of depression in nearly one-quarter of a large Australian depression cohort—a finding that strengthens the case for investigating light’s role in mental health, without establishing that architectural lighting can treat the condition.

Published October 20 in The British Journal of Psychiatry, the study examined 11,380 participants in the Australian Genetics of Depression Study. Researchers classified 2,604, or 23%, as having a circadian depression profile. These participants reported earlier illness onset, more severe symptoms and poorer responses to commonly prescribed antidepressants.

For lighting manufacturers, specifiers and building owners, the important distinction is between an emerging clinical research opportunity and a proven product application.

A Pattern Beyond Seasonal Depression

The team, led by Emiliana Tonini and colleagues, classified participants using six self-reported features: seasonality, delayed sleep midpoint, evening preference, morning tiredness, excessive sleeping during depression and social jetlag—the mismatch between sleep timing on working and nonworking days. Participants meeting at least three criteria entered the circadian group.

Depression began at an average age of approximately 19 in this group, compared with 23 among other participants. The circadian group also reported greater psychological distress, suicidal ideation and other severe symptoms. Genetic associations with eveningness and later sleep timing added biological support, although the authors describe the classification as provisional.

Seasonality appeared in only 41% of circadian cases, underscoring that the proposed profile extends beyond familiar wintertime mood changes.

Implications for Lighting Practice

The study makes timing a particularly relevant topic for the lighting industry. However, it did not measure participants’ light exposure, evaluate luminaires or test light therapy. It therefore cannot establish that inadequate indoor lighting caused their depression—or that tunable-white installations would improve it.

Existing light-exposure guidance provides a more defensible foundation for design. A separate expert consensus recommends, for healthy adults, at least 250 lux melanopic equivalent daylight illuminance during daytime, no more than 10 during the three hours before bedtime, and less than one during sleep. These are eye-level exposure targets, not conventional horizontal workplane illuminance requirements.

Melanopic EDI expresses light exposure according to its stimulation of melanopsin-sensitive retinal pathways involved in circadian responses. For specifiers, that means evaluating the light reaching occupants’ eyes and its spectrum—not simply selecting a correlated color temperature or adding a “circadian” label. Daylight is the consensus group’s preferred first option for meeting daytime targets where available.

Research Opportunity, Not a Treatment Claim

The strongest commercial implication is an opportunity for rigorous collaboration: lighting companies, building researchers and clinicians could test whether measured, appropriately timed light interventions improve outcomes in clearly defined patient groups.

Such trials must distinguish everyday supportive lighting from prescribed treatment. The Sydney findings concern associations, and medication responses were self-reported. The sample predominantly involved severe, recurrent depression, was 75% female and included only participants of genetically inferred European ancestry, limiting generalization.

For now, the study supports better questions and stronger research partnerships—not depression-treatment promises on a luminaire specification sheet.

The full research report can be found here.

Top image courtesy of Pexels.com

David Shiller

David Shiller is the Publisher of LightNOW, and Senior Business Development Consultant at Capacity Consulting, a North American consulting firm providing business development services to advanced lighting manufacturers. The ALA awarded David the Pillar of the Industry Award. David has been co-chair of the ALA’s Engineering Committee since 2010. David established MaxLite’s OEM component sales into a multi-million dollar division. He invented GU24 lamps while leading ENERGY STAR lighting programs for the US EPA. David has been published in leading lighting publications, including LD+A, enLIGHTenment Magazine, LEDs Magazine, and more.

See Full Bio